Report error Found 25 Enz. Inhib. hit(s) with all data for entry = 50017838
Affinity DataIC50: 3.40nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 3.70nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 3.90nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 7.10nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 34nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 34nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 41nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 41nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 51nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 71nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 81nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 91nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 129nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 140nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 154nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 164nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 171nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 217nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 234nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 287nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 313nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+3nMAssay Description:Negative allosteric modulation activity against human ATX using FS-3 as substrate preincubated for 45 mins followed by substrate addition and measure...More data for this Ligand-Target Pair
